moderate - Defense and aerospace spending shows relative GDP insensitivity due to multi-year budget cycles and national security priorities. However, commercial EV adoption and battery production investment (key growth markets) correlate with industrial capex cycles and consumer vehicle demand. Economic weakness could delay commercial customer qualification timelines and production ramp decisions.

High sensitivity through multiple channels: (1) As a cash-burning growth company, higher rates increase discount rates applied to distant cash flows, compressing valuation multiples; (2) Rising rates reduce venture capital and growth equity availability, threatening future financing rounds; (3) Higher rates slow EV adoption by increasing vehicle financing costs, delaying addressable market expansion. Current ratio of 4.12 provides near-term liquidity buffer, but sustained operations require either revenue inflection or continued capital access.

growth/speculative - Attracts early-stage technology investors willing to accept high volatility and binary outcomes in exchange for potential multi-bagger returns if thermal management solutions achieve broad commercial adoption. The 83% one-year decline and -47% six-month return reflect typical pre-revenue biotech/cleantech volatility patterns. Not suitable for value or income investors given negative earnings, no dividend, and uncertain path to profitability.